Skip to main content

Table 3 Results of Meta-analysis of diastolic blood pressure

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study | SMD [95% Conf. Interval] % Weight
Carter (1997) [8] | 0.110 −0.439 0.660 8.55
Carter (2009) [15] | -0.108 −0.304 0.087 18.74
Schumacher (2018) | -0.654 −0.884 −0.424 17.58
Korcegez (2017) | -0.584 −0.908 −0.259 14.37
Domingues (2017) [40] | -0.285 −0.715 0.144 11.27
Javaid (2019) [42] | -0.402 −0.752 −0.052 13.57
Shao (2017) | -0.203 −0.482 0.075 15.91
D + L pooled SMD | -0.329 −0.532 −0.125 100.00
  1. Heterogeneity chi-squared =18.35 (d.f. = 6) p = 0.005.
  2. I-squared (variation in SMD attributable to heterogeneity) = 67.3%.
  3. Estimate of between-study variance Tau-squared = 0.0476.
  4. Test of SMD = 0: z = 3.17 p = 0.002.
  5. The significance level of the combined effect quantity test: 0.05.
  6. The significance level of the heterogeneity test: 0.1.
  7. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.